MEHA Functional Brands Inc.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1837254 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.1%
TTM net income YoY-2,452.2%
TTM EPS YoY-340.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin55.8%
Operating margin-51.8%
Net margin-142.5%
FCF margin—
EBITDA margin-51.6%
Returns
ROE—
ROA-132.2%
ROIC (approx.)—
Asset turnover0.93x
Leverage & solvency
Liabilities / assets160.0%
Debt / equity—
Current ratio0.30x
Interest coverage-7.66x
Cash quality & payout
Operating cash flow / net income0.40x
Accruals ratio-79.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.65M | $1.87M | $1.65M | $1.49M | $1.69M | $1.83M | $1.59M | $1.68M |
| Cost of revenue | $684,289 | $750,207 | $684,391 | $823,766 | $715,824 | $864,437 | $723,492 | $690,623 |
| Gross profit | $960,764 | $1.12M | $961,133 | $670,755 | $978,350 | $968,095 | $866,764 | $989,473 |
| SG&A expense | $1.08M | $2.10M | $1.38M | $1.63M | $937,762 | $958,493 | $720,234 | $1.00M |
| Operating income | -$314,762 | -$1.32M | -$682,805 | -$1.13M | -$78,288 | -$155,437 | -$32,100 | -$135,747 |
| Interest expense | $246,165 | $97,801 | $25,804 | $80,981 | $155,310 | $71,012 | $95,094 | $142,284 |
| Net income | -$714,455 | -$2.63M | -$6.99M | $852,315 | $259,001 | -$226,056 | -$126,782 | -$277,750 |
| EBITDA | -$310,369 | -$1.32M | -$678,223 | -$1.13M | -$73,346 | -$149,212 | -$25,875 | -$127,952 |
| EPS (basic) | -0.01 | -0.06 | -0.36 | — | 0.04 | -0.03 | -0.02 | — |
| EPS (diluted) | -0.01 | -0.06 | -0.36 | — | 0.04 | -0.03 | -0.02 | — |
| Weighted avg. shares (diluted) | 64.92M | 42.67M | 19.59M | — | 7.20M | 6.95M | 6.92M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $231,900 | $352,142 | $1.08M | $2.73M | $1.01M | $257,682 | $213,631 | $211,642 |
| Receivables | $298,965 | $503,440 | $372,712 | $518,474 | $89,213 | — | — | $303,471 |
| Inventory | $1.71M | $1.68M | $1.59M | $1.55M | $1.69M | — | — | $1.71M |
| Current assets | $2.51M | $2.74M | $3.40M | $5.19M | $4.21M | — | — | $2.86M |
| PP&E, net | $23,890 | $28,283 | $32,797 | $37,379 | $42,086 | — | — | $49,564 |
| Goodwill | $818,139 | $818,139 | $818,139 | $818,139 | $818,139 | — | — | $818,139 |
| Intangibles | $1.36M | $1.37M | $1.39M | $1.40M | $1.41M | — | — | $1.44M |
| Total assets | $6.12M | $6.45M | $7.21M | $9.11M | $8.23M | — | — | $7.17M |
| Current liabilities | $8.32M | $5.65M | $2.84M | $5.75M | $5.70M | — | — | $5.20M |
| Short-term debt | — | — | — | $154,957 | — | — | — | — |
| Long-term debt | $137,780 | $138,680 | $139,571 | $140,468 | $141,327 | — | — | — |
| Total debt | $137,780 | $138,680 | $139,571 | $295,425 | $141,327 | — | — | — |
| Total liabilities | $9.78M | $9.41M | $11.72M | $7.57M | $7.63M | — | — | $7.29M |
| Shareholders' equity | -$3.67M | -$2.96M | -$4.51M | $1.54M | $604,665 | $257,164 | $153,013 | -$118,577 |
| Net debt | -$94,120 | -$213,462 | -$938,396 | -$2.43M | -$863,997 | — | — | — |
| Shares outstanding | 64.92M | 64.92M | 21.35M | 18.70M | 7.08M | — | — | 6.69M |
| Cash flow statement | ||||||||
| Operating cash flow | -$74,755 | -$518,898 | -$424,559 | -$2.75M | $830,601 | $471,764 | $175,993 | $56,168 |
| Capital expenditure | — | — | — | $1 | — | — | — | $0 |
| Free cash flow | — | — | — | -$2.75M | — | — | — | $56,168 |
| Investing cash flow | — | — | — | -$1 | — | — | — | $0 |
| Financing cash flow | -$45,487 | -$206,927 | -$1.22M | $4.47M | -$74,447 | -$427,713 | -$174,004 | -$94,696 |
| Depreciation & amortization | $4,393 | $4,512 | $4,582 | $4,708 | $4,942 | $6,225 | $6,225 | $7,795 |
| Stock-based compensation | $0 | $314,685 | $123,288 | -$55,788 | $88,500 | $257,451 | $252,905 | — |
| Dividends paid | $0 | — | — | — | — | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 9 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.